Teva to regain generics lead with Ivax purchase
Teva Pharmaceutical Industries continued its bid for world domination in the generic pharmaceuticals sector yesterday with a $7.4 billion cash and stock bid for US company Ivax, reports Phil Taylor.
Archives for July 25, 2005
Sirna demonstrates siRNA efficacy
The first study of systemic siRNA efficacy at therapeutically relevant doses has been published by Sirna Therapeutics, who have demonstrated an almost complete reduction of the hepatitis B virus (HBV). The study establishes a strong scientific...
Acambis commences C. difficile vaccine trial
Acambis has commenced clinical trials of its investigational vaccine against Clostridium difficile (C. difficile) - a common hospital-acquired infection, in which a new virulent strain has emerged, causing sharp increases in the number of infections...
Price increases keep Akzo Nobel on track in 2Q
Dutch pharmaceuticals and chemicals giant Akzo Nobel reported second-quarter sales of €3.34 billion, up 6 per cent from the comparable period in 2004, thanks to price increases that overcame flat volumes.
J&JPRD and Hurel enter scientific collaboration
Johnson & Johnson Pharmaceutical Research and Development (J&JPRD) and the Hurel Corporation have entered into a joint scientific collaboration to develop microfluidic, technology, with a view to launching the world's first in vitro test of first-pass...
Laboratory tool reveals linked loci
An improved new statistical method developed by genome researchers, is set to streamline the computation required to identify the potential locations in the genome, as well as linking more gene expression traits to two loci.
FlexPac to expand into pharma after Blackard acquisition
The acquisition of Flexible Packaging (FlexPac) of the US by the Blackard Group will spur the development of the company's technology into new industrial sectors, including pharmaceuticals.